3/14
05:39 pm
iron
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
Low
Report
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
3/12
09:00 am
iron
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates
Medium
Report
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates
3/11
09:00 am
iron
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine
Medium
Report
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine
3/10
08:44 pm
iron
Evaluating Disc Medicine (IRON) After Recent Share Moves And Conflicting Valuation Signals [Yahoo! Finance]
Medium
Report
Evaluating Disc Medicine (IRON) After Recent Share Moves And Conflicting Valuation Signals [Yahoo! Finance]
3/3
03:37 pm
iron
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
3/2
10:56 am
iron
Disc Medicine (IRON) had its price target raised by Wells Fargo & Company from $78.00 to $79.00. They now have an "overweight" rating on the stock.
Low
Report
Disc Medicine (IRON) had its price target raised by Wells Fargo & Company from $78.00 to $79.00. They now have an "overweight" rating on the stock.
3/1
02:36 pm
iron
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection [Yahoo! Finance]
Medium
Report
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection [Yahoo! Finance]
2/28
10:27 am
iron
Disc Medicine (IRON) Is Up 8.6% After Wider 2025 Losses And New Shelf Registration - What's Changed [Yahoo! Finance]
Medium
Report
Disc Medicine (IRON) Is Up 8.6% After Wider 2025 Losses And New Shelf Registration - What's Changed [Yahoo! Finance]
2/27
01:11 pm
iron
Disc Medicine (IRON) had its price target lowered by Truist Financial Corporation from $114.00 to $83.00. They now have a "buy" rating on the stock.
Low
Report
Disc Medicine (IRON) had its price target lowered by Truist Financial Corporation from $114.00 to $83.00. They now have a "buy" rating on the stock.
2/26
03:12 pm
iron
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
2/26
08:54 am
iron
Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
2/26
08:30 am
iron
Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Low
Report
Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2/25
04:04 pm
iron
Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction [Yahoo! Finance]
Low
Report
Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction [Yahoo! Finance]
2/25
03:25 pm
iron
Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst [Yahoo! Finance]
Low
Report
Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst [Yahoo! Finance]
2/24
05:23 pm
iron
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
2/24
08:55 am
iron
Disc Medicine to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Disc Medicine to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/24
08:30 am
iron
Disc Medicine to Participate in Upcoming Investor Conferences
Medium
Report
Disc Medicine to Participate in Upcoming Investor Conferences
2/23
04:41 pm
iron
Disc Medicine to Seek Traditional FDA Approval for Bitopertin After EPP CRL; APOLLO Data Due Q4 [Yahoo! Finance]
Medium
Report
Disc Medicine to Seek Traditional FDA Approval for Bitopertin After EPP CRL; APOLLO Data Due Q4 [Yahoo! Finance]
2/19
08:06 pm
iron
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
2/19
12:30 pm
iron
Disc Medicine: Downgrading As CRL Puts APOLLO Study Into Question [Seeking Alpha]
Low
Report
Disc Medicine: Downgrading As CRL Puts APOLLO Study Into Question [Seeking Alpha]
2/19
05:35 am
iron
Disc Medicine (IRON) Valuation Check After FDA Complete Response Letter On Lead Bitopertin Program [Yahoo! Finance]
Low
Report
Disc Medicine (IRON) Valuation Check After FDA Complete Response Letter On Lead Bitopertin Program [Yahoo! Finance]
2/17
04:58 pm
iron
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
2/17
10:58 am
iron
Disc Medicine (NASDAQ:IRON) was given a new $110.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
Disc Medicine (NASDAQ:IRON) was given a new $110.00 price target on by analysts at Stifel Nicolaus.
2/17
10:42 am
iron
Disc Medicine After The CRL: Risk Now Rests On APOLLO [Seeking Alpha]
Medium
Report
Disc Medicine After The CRL: Risk Now Rests On APOLLO [Seeking Alpha]
2/17
10:04 am
iron
Disc Medicine (NASDAQ:IRON) was given a new $125.00 price target on by analysts at Cantor Fitzgerald.
Medium
Report
Disc Medicine (NASDAQ:IRON) was given a new $125.00 price target on by analysts at Cantor Fitzgerald.